PCED1A as a Predictive Biomarker for Immunotherapy and Anti-Angiogenic Treatment in Hepatocellular and Colorectal Cancer. Filho VOC, Passos PRC. J Gastroenterol Hepatol 2025 Apr 9. doi: 10.1111/jgh.16969.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Filho VOC, Passos PRC. PCED1A as a Predictive Biomarker for Immunotherapy and Anti-Angiogenic Treatment in Hepatocellular and Colorectal Cancer. J Gastroenterol Hepatol 2025 Apr 9. doi: 10.1111/jgh.16969.
PMID: 40204675